184 related articles for article (PubMed ID: 12454560)
1. Review of the use of topiramate for treatment of bipolar disorders.
Suppes T
J Clin Psychopharmacol; 2002 Dec; 22(6):599-609. PubMed ID: 12454560
[TBL] [Abstract][Full Text] [Related]
2. The use of topiramate in mood stabilization.
Maidment ID
Ann Pharmacother; 2002; 36(7-8):1277-81. PubMed ID: 12086564
[TBL] [Abstract][Full Text] [Related]
3. The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder.
Chengappa KN; Gershon S; Levine J
Bipolar Disord; 2001 Oct; 3(5):215-32. PubMed ID: 11912568
[TBL] [Abstract][Full Text] [Related]
4. Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials.
Kushner SF; Khan A; Lane R; Olson WH
Bipolar Disord; 2006 Feb; 8(1):15-27. PubMed ID: 16411977
[TBL] [Abstract][Full Text] [Related]
5. Newer antiepileptic drugs in bipolar disorder: rationale for use and role in therapy.
Macdonald KJ; Young LT
CNS Drugs; 2002; 16(8):549-62. PubMed ID: 12096935
[TBL] [Abstract][Full Text] [Related]
6. Topiramate: a new antiepileptic drug.
Privitera MD
Ann Pharmacother; 1997 Oct; 31(10):1164-73. PubMed ID: 9337443
[TBL] [Abstract][Full Text] [Related]
7. Third generation anticonvulsants in bipolar disorder: a review of efficacy and summary of clinical recommendations.
Yatham LN; Kusumakar V; Calabrese JR; Rao R; Scarrow G; Kroeker G
J Clin Psychiatry; 2002 Apr; 63(4):275-83. PubMed ID: 12000201
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness and safety of topiramate in treatment-resistant bipolar disorder].
Vieta E; Gilabert A; Rodríguez A; García-Castrillón A; Luna MJ; Arrufat E; García-Parés G
Actas Esp Psiquiatr; 2001; 29(3):148-52. PubMed ID: 11412488
[TBL] [Abstract][Full Text] [Related]
9. Open-label adjunctive topiramate in the treatment of bipolar disorders.
McElroy SL; Suppes T; Keck PE; Frye MA; Denicoff KD; Altshuler LL; Brown ES; Nolen WA; Kupka RW; Rochussen J; Leverich GS; Post RM
Biol Psychiatry; 2000 Jun; 47(12):1025-33. PubMed ID: 10862801
[TBL] [Abstract][Full Text] [Related]
10. Topiramate can cause lithium toxicity.
Abraham G; Owen J
J Clin Psychopharmacol; 2004 Oct; 24(5):565-7. PubMed ID: 15349023
[No Abstract] [Full Text] [Related]
11. Antidepressant properties of anticonvulsant drugs for bipolar disorder.
Ernst CL; Goldberg JF
J Clin Psychopharmacol; 2003 Apr; 23(2):182-92. PubMed ID: 12640220
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders.
Evins AE
J Clin Psychiatry; 2003; 64 Suppl 8():9-14. PubMed ID: 12892536
[TBL] [Abstract][Full Text] [Related]
13. Topiramate: New preparation. Helpful in refractory partial epilepsy.
Prescrire Int; 1999 Feb; 8(39):3-5. PubMed ID: 10557563
[TBL] [Abstract][Full Text] [Related]
14. Add-on topiramate reduces weight in overweight patients with affective disorders: a clinical case series.
Kirov G; Tredget J
BMC Psychiatry; 2005 Apr; 5():19. PubMed ID: 15817130
[TBL] [Abstract][Full Text] [Related]
15. Adjunctive topiramate in the maintenance treatment of bipolar disorders: an open-label study.
Lykouras L; Hatzimanolis J
Curr Med Res Opin; 2004 Jun; 20(6):843-7. PubMed ID: 15200741
[TBL] [Abstract][Full Text] [Related]
16. Effects on weight and outcome of long-term olanzapine-topiramate combination treatment in bipolar disorder.
Vieta E; Sánchez-Moreno J; Goikolea JM; Colom F; Martínez-Arán A; Benabarre A; Corbella B; Torrent C; Comes M; Reinares M; Brugue E
J Clin Psychopharmacol; 2004 Aug; 24(4):374-8. PubMed ID: 15232327
[TBL] [Abstract][Full Text] [Related]
17. Open-label adjunctive topiramate in the treatment of unstable bipolar disorder.
McIntyre RS; Riccardelli R; Binder C; Kusumakar V
Can J Psychiatry; 2005 Jun; 50(7):415-22. PubMed ID: 16086539
[TBL] [Abstract][Full Text] [Related]
18. Novel anticonvulsants: a new generation of mood stabilizers?
Ghaemi SN; Gaughan S
Harv Rev Psychiatry; 2000; 8(1):1-7. PubMed ID: 10824292
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study.
Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L
Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of adjunctive topiramate treatment in a sample of refractory bipolar patients with comorbid conditions.
Guille C; Sachs G
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1035-9. PubMed ID: 12452523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
